Neurobiological Tech (NTII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII)

NTII 0.0001000

0.0%

Jan 9 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dr. John M. de Castro who wrote (445)	2/12/1999 4:06:00 PM
From: Biomaven	Read Replies (1) of 1494

John, I believe the memantine trials (neuropathy and AIDS dementia) are required by their agreement with Merz. I guess the Xerecept trial could be suspended if they are desperate (although this is the one they just got a grant for). My instinct is that they will get some sort of funding and be able to continue - there's enough potential value here to warrant funding. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next